Return to Results

Gore Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease (VIPER)

new search

Trial Conditions
  • Superficial Femoral Artery Disease
What is the purpose of this trial?

To collect information and evaluate the performance of the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface when used in the Superficial Femoral Artery.

Date & Status



Time: Baseline Visit, 1 month visit/telephone call, 6 month visit, and 12 month visit.

Inclusion:  Subjects at least 21 years of age with lifestyle-limiting claudication, rest pain, or tissue loss affecting a lower extremity.  Subjects with an ankle brachial index of  0.9 or less with a life expectancy of at least 12 months. 

  • St. Elizabeth's Medical Center - Recruiting
Other Information

Sponsor: W.L. Gore & Associates
Phase: Phase 4
Trial ID: SFA Disease
Volunteers:  Not Accepting Healthy Volunteers

new search

Connect with Steward

Visit Our Twitter Feed Visit Our Facebook Page Email This Page Print This Page

Subscribe to our patient e-newsletter

Copyright © 2015 Steward Health Care
Connect Healthcare Panacea CMS Solutions